Edition:
United States

Enanta Pharmaceuticals Inc (ENTA.OQ)

ENTA.OQ on NASDAQ Stock Exchange Global Select Market

48.13USD
11:09am EST
Change (% chg)

$0.45 (+0.94%)
Prev Close
$47.68
Open
$47.58
Day's High
$48.60
Day's Low
$46.92
Volume
28,185
Avg. Vol
76,063
52-wk High
$50.89
52-wk Low
$25.92

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 2.13 September 24 Nov 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 3 3 3 2
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.25 2.25 2.25 2.33

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-17 4 73.80 75.76 72.00 --
Quarter Ending Mar-18 3 17.08 21.00 12.93 --
Year Ending Sep-17 4 100.72 102.65 99.00 --
Year Ending Sep-18 4 85.18 97.00 69.44 --
Year Ending Sep-19 2 102.20 124.00 80.40 --
Earnings (per share)
Quarter Ending Sep-17 4 2.13 2.83 1.81 --
Quarter Ending Mar-18 1 -0.75 -0.75 -0.75 --
Year Ending Sep-17 4 1.16 1.87 0.83 --
Year Ending Sep-18 4 -1.39 -0.46 -2.36 --
Year Ending Sep-19 2 -0.82 -0.62 -1.03 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 73.80 75.93 2.13 2.88
Quarter Ending Jun-17 8.07 7.51 0.56 6.98
Quarter Ending Mar-17 9.19 8.96 0.23 2.53
Quarter Ending Dec-16 11.94 10.42 1.52 12.72
Quarter Ending Sep-16 13.22 12.84 0.38 2.90

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-17 73.80 -- -- -- --
Quarter Ending Mar-18 17.08 12.93 12.93 12.93 --
Year Ending Sep-17 100.72 -- -- -- --
Year Ending Sep-18 85.18 69.92 67.90 67.90 --
Year Ending Sep-19 102.20 76.75 76.75 76.75 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-17 -- -- -- --
Quarter Ending Mar-18 0 0 0 0
Year Ending Sep-17 -- -- -- --
Year Ending Sep-18 3 0 3 0
Year Ending Sep-19 1 0 1 0
Earnings